CMS Rule Would Increase Cost Transparency of Medicaid-Covered Drugs. | JAMA;329(24): 2118, 2023 06 27. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

Brasil - Virtual Health Library

Information and Knowledge for Health

Subject descriptor lookup Advanced Search

CMS Rule Would Increase Cost Transparency of Medicaid-Covered Drugs.

Harris, Emily.

JAMA ; 329(24): 2118, 2023 06 27.

Article in En | MEDLINE | ID: mdl-37285174

Subject(s)

Centers for Medicare and Medicaid Services, U.S.; Drug Costs; Medicaid; Medicare; Centers for Medicare and Medicaid Services, U.S./economics; Centers for Medicare and Medicaid Services, U.S./legislation & jurisprudence; Insurance, Pharmaceutical Services; Medicaid/economics; Medicaid/legislation & jurisprudence; United States; Drug Costs/legislation & jurisprudence

Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 Database: MEDLINE Main subject: Centers for Medicare and Medicaid Services, U.S. / Medicare / Medicaid / Drug Costs Type of study: Health_economic_evaluation Country/Region as subject: America do norte Language: En Journal: JAMA Year: 2023 Document type: Article

Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 Database: MEDLINE Main subject: Centers for Medicare and Medicaid Services, U.S. / Medicare / Medicaid / Drug Costs Type of study: Health_economic_evaluation Country/Region as subject: America do norte Language: En Journal: JAMA Year: 2023 Document type: Article